Roceso Technologies is a world pioneer in soft robotic exoskeleton technologies and leader in neurological technologies. Its soft robotic solutions provide functional assistance to patients with limb motor function impairments during rehabilitation and daily living. The company’s flagship product, the EsoGLOVETM, is one of the world lightest hand rehabilitation and exoskeleton devices offering top functionality and comfort. 
Founded in 2016 by Ms. Jane WANG, Dr. Hong Kai YAP, Dr. Raye YEOW, Roceso Technologies is ISO13485:2016 certified for design, manufacturing, storage and distribution of medical devices. EsoGLOVETM Hand Rehabilitation System has been registered with FDA, approved by EU CE, Singapore HSA, Japan FDA, Korea FDA, Malaysia MDA and Australia TGA. 

On top of EsoGLOVETM system, Roceso Technologies is also offering rehabilitation assessment, gamification and platform technologies. The company has clinical partners around the globe and distribution network in more than 10 countries. Cygni Advanced Neurorehabilitation Centre, Roceso’s clinical arm, started operating since April 2022 in Central Singapore.